Passive Euthanasia and Harish Rana: Law, Procedure, and the Limits of Medical Boards

Introduction

The Supreme Court’s direction to AIIMS, New Delhi to constitute a secondary medical board to examine 32‑year‑old Harish Rana — who has been in a vegetative state for some 13 years — has brought the law on passive euthanasia back into sharp focus. The matter is legally significant because it raises core questions about the interplay of individual autonomy, medical judgment and judicial oversight under Article 21 of the Constitution. The court’s renewed attention also tests the practical efficacy of the procedures laid down in judicial precedents for living wills and withdrawal of life‑support, particularly where long periods of incapacitation and disputed medical opinions obtain.

Legal Background

Indian jurisprudence on end‑of‑life decisions rests principally on three authorities. In Gian Kaur v State of Punjab (1996) the Court rejected a broad recognition of a “right to die” while preserving the sanctity of life guarantee under Article 21. Subsequent developments culminated in Common Cause v Union of India (2018), where a five‑judge Constitution Bench recognised passive euthanasia in limited circumstances and validated the concept of an advance directive or “living will.” The Common Cause judgment also prescribed procedural safeguards — including medical boards for assessment — intended to prevent abuse. Earlier, Aruna Shanbaug v Union of India (2011) had permitted withdrawal of life support in an exceptional persistent vegetative state on judicial review. The Supreme Court’s January 2023 modifications to the Common Cause framework (as reported in the news) purportedly eased certain procedural requirements to make implementation less burdensome on families and treating institutions. International authorities such as Airedale NHS Trust v Bland [1993] AC 789 inform the distinction between active and passive forms of ending life: common law tends to permit withdrawal of disproportionate or futile treatment but bars positive steps to cause death.

Critical Analysis

At the heart of the Harish Rana matter are three discrete legal issues: (1) whether the statutory and judicial safeguards for passive euthanasia have been met in fact; (2) the correct institutional role of primary and secondary medical boards; and (3) the boundary between judicial supervision and medical expertise. Common Cause envisages a structured, evidentiary process: a competent person may execute a living will, and where a patient lacks capacity, a medical board must determine prognosis and appropriateness of continued treatment. The Supreme Court’s order for a secondary medical board at AIIMS reflects that scheme — it provides a fresh, independent clinical opinion where the primary board’s findings may be contested or where the stakes are high.

Two features demand emphasis. First, the presence or absence of a valid living will materially alters the legal calculus. If Harish Rana executed a clear, contemporaneous advance directive, autonomy carries substantial weight; absent such a directive, courts will balance best interests, family testimony and medical evidence with far greater caution. Second, the quality and composition of the medical boards are pivotal. Common Cause contemplated multi‑disciplinary assessment, including neurologists and intensivists, with careful documentation of irreversibility and prognosis. A secondary board’s role is not merely perfunctory review; it must transparently re‑examine diagnostic criteria for vegetative or minimally conscious states, the possibility of recovery, and burdens of treatment.

Several procedural pitfalls recur in such cases. Medical boards sometimes reach divergent conclusions due to differing diagnostic criteria or unavailable historical records. Courts must therefore ensure that board reports are reasoned, cite objective tests (EEG, MRI, standardized consciousness scales) and explain why continued treatment is futile. International precedents show that where prognostic certainty is low, judicial restraint against authorising withdrawal is prudent. Conversely, indefinite prolongation of life‑support that only preserves biological existence without prospects of recovery raises dignity concerns recognised in Article 21 jurisprudence.

Missing facts (hypothetical): the public reports do not disclose whether Harish Rana executed a living will, the exact composition and findings of the primary medical board, or whether family members are united in seeking withdrawal. These gaps are legally material and will shape the Court’s calculus.

Opinion & Outlook

Practically, the Supreme Court is likely to treat the secondary board’s findings as decisive but not conclusive — the judiciary will retain supervisory jurisdiction to assure procedural fairness and to guard against errors of medical judgment or potential coercion. Where a valid living will exists and medical evidence corroborates irreversible prognosis, the Court may authorise withdrawal under the Common Cause framework. If no living will exists, the Court will undertake a stricter balancing exercise and may require additional safeguards: contemporaneous family consultations, psychiatric input, and periodic review mechanisms before authorising withdrawal.

The episode highlights a legislative gap. Reliance on judicially crafted procedures produces uncertainty and uneven implementation across hospitals. A statutory framework would better calibrate evidentiary standards for living wills, create a national registry, prescribe minimum qualifications and composition for medical boards, and build independent review layers to avoid ad hoc litigation. Training for clinicians and standardised neurological assessment protocols would reduce divergences between primary and secondary boards and reduce litigation.

Conclusion

The Supreme Court’s order for a secondary medical board in the Harish Rana case is a measured application of Common Cause’s safeguards: it preserves the centrality of medical evidence while retaining judicial oversight to protect dignity and prevent abuse. The outcome will turn on missing factual predicates — notably the existence of any living will and the medical boards’ reasoned findings — but the case underscores the urgent need for clearer statutory guidance to manage end‑of‑life choices consistently, compassionately and lawfully.

(References: Common Cause v Union of India (2018); Aruna Shanbaug v Union of India (2011); Gian Kaur v State of Punjab (1996); Airedale NHS Trust v Bland [1993] AC 789.)